Search results for:

26 results

International Comparative Legal Guide to Restructuring & Insolvency 2021 - Belgium & Netherlands chapter

The ICLG to Restructuring & Insolvency 2021 covers common issues in restructuring and insolvency, incl. issues that arise when a company is in financial difficulties, restructuring options, insolvency procedures, tax, employees and cross-border issues.

Good things are worth waiting for: new law amendments in force for companies in difficulty

The long-awaited new law amending Book XX of the Code of Economic Law and the Income Tax Code 1992 just came into force. This replaces the "COVID-moratorium" and creates the possibility to restructure a company through a “preparatory agreement”.

Stibbe advises GRW on the acquisition of Van Hool’s industrial vehicle division

Stibbe advised GRW, the South African tanker and trailer manufacturer allied with Schmitz Cargobull, on acquiring the industrial vehicle division of Van Hool, following the latter’s declaration of bankruptcy.

Het federale regeerakkoord door een publiekrechtelijke bril

De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.

Stibbe advises LDA Capital

Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.

International Comparative Legal Guide - Restructuring & Insolvency 2025 - Belgium Chapter

Pieter Wouters contributed to the 19th edition of ICLG – Restructuring & Insolvency, offering a detailed Q&A overview of Belgian insolvency and restructuring law, including key considerations and common pitfalls to avoid.

Stibbe advises DW Healthcare Partners

Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.

Stibbe advises Nyobe NV

Stibbe assisted Nyobe NV with its judicial reorganisation procedure with a view of transferring Nyobe’s activities under the court’s supervision, after Nyobe was confronted with a fiscal claim of 100 million euro.

Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe

Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Stibbe advises pharmaceutical multinational

Stibbe assisted a pharmaceutical multinational in complex litigations.

Stibbe represents major insurance company

Stibbe represented a major insurance company in its defence before the Brussels Court against a group of claimants who purchased life insurance schemes linked to Traded Endowment Funds.

Stibbe advises KBC Securities

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.

Stibbe advises worldwide seeds leader

Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.

Stibbe advises leading pharmaceutical company

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.

Stibbe advises client in the pharmaceutical sector

Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.

Stibbe advises leading plasma protein biotherapeutics company

Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.

Stibbe advises the Gemeentelijke Holding

Stibbe advised the directors of the Gemeentelijke Holding, one of the main historical shareholders of Dexia NV, throughout the entire crisis period.

Stibbe advises biotech company

Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.

SearchSearch results for: “”